Skip to Content



Definition: An antineoplastic tyrosine kinase inhibitor used in the treatment of malignancies harboring the BCR-ABL protein.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.